FDA's Safety Role in Question After Egg Recall

Publication: Newshour

09/01/2010 - A massive egg recall over fears of a salmonella outbreak raises new questions on whether the Food and Drug Administration can handle its regulatory role.


Allan Coukell, a pharmacist and director of the medical safety program at the Pew Health Group, says, in the last decade, the number of plants in India and China making ingredients for the American market has doubled, at a time when FDA has fewer resources to inspect them.

ALLAN COUKELL, Pew Health Group: If you're manufacturing overseas, you might never see an inspector after the initial inspection at the beginning of your manufacturing process.

To view, or a read a transcript of FDA's Safety Role in Question After Egg Recall, visit the Newshour Web site.

(All Fields are required)